Neurocrine Biosciences Statistics
Total Valuation
NBIX has a market cap or net worth of $14.86 billion. The enterprise value is $14.94 billion.
| Market Cap | 14.86B |
| Enterprise Value | 14.94B |
Important Dates
The next estimated earnings date is Tuesday, October 27, 2026, after market close.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NBIX has 101.65 million shares outstanding. The number of shares has increased by 0.78% in one year.
| Current Share Class | 101.65M |
| Shares Outstanding | 101.65M |
| Shares Change (YoY) | +0.78% |
| Shares Change (QoQ) | +0.77% |
| Owned by Insiders (%) | 1.18% |
| Owned by Institutions (%) | 101.44% |
| Float | 100.37M |
Valuation Ratios
The trailing PE ratio is 21.43 and the forward PE ratio is 13.09. NBIX's PEG ratio is 0.32.
| PE Ratio | 21.43 |
| Forward PE | 13.09 |
| PS Ratio | 4.41 |
| Forward PS | 3.42 |
| PB Ratio | 4.02 |
| P/TBV Ratio | 15.37 |
| P/FCF Ratio | 17.08 |
| P/OCF Ratio | 16.55 |
| PEG Ratio | 0.32 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.35, with an EV/FCF ratio of 17.16.
| EV / Earnings | 21.17 |
| EV / Sales | 4.43 |
| EV / EBITDA | 16.35 |
| EV / EBIT | 17.25 |
| EV / FCF | 17.16 |
Financial Position
The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.87 |
| Quick Ratio | 1.46 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.47 |
| Debt / FCF | 0.53 |
| Interest Coverage | 298.62 |
Financial Efficiency
Return on equity (ROE) is 22.09% and return on invested capital (ROIC) is 20.56%.
| Return on Equity (ROE) | 22.09% |
| Return on Assets (ROA) | 11.70% |
| Return on Invested Capital (ROIC) | 20.56% |
| Return on Capital Employed (ROCE) | 19.31% |
| Weighted Average Cost of Capital (WACC) | 6.17% |
| Revenue Per Employee | $1.69M |
| Profits Per Employee | $352,750 |
| Employee Count | 2,000 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 14.88 |
Taxes
In the past 12 months, NBIX has paid $234.70 million in taxes.
| Income Tax | 234.70M |
| Effective Tax Rate | 24.96% |
Stock Price Statistics
The stock price has increased by +2.45% in the last 52 weeks. The beta is 0.38, so NBIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | +2.45% |
| 50-Day Moving Average | 162.24 |
| 200-Day Moving Average | 147.94 |
| Relative Strength Index (RSI) | 33.41 |
| Average Volume (20 Days) | 1,095,878 |
Short Selling Information
The latest short interest is 5.06 million, so 4.97% of the outstanding shares have been sold short.
| Short Interest | 5.06M |
| Short Previous Month | 4.55M |
| Short % of Shares Out | 4.97% |
| Short % of Float | 5.04% |
| Short Ratio (days to cover) | 3.68 |
Income Statement
In the last 12 months, NBIX had revenue of $3.37 billion and earned $705.50 million in profits. Earnings per share was $6.82.
| Revenue | 3.37B |
| Gross Profit | 2.18B |
| Operating Income | 866.00M |
| Pretax Income | 940.20M |
| Net Income | 705.50M |
| EBITDA | 913.30M |
| EBIT | 866.00M |
| Earnings Per Share (EPS) | $6.82 |
Balance Sheet
The company has $389.80 million in cash and $461.60 million in debt, with a net cash position of -$71.80 million or -$0.71 per share.
| Cash & Cash Equivalents | 389.80M |
| Total Debt | 461.60M |
| Net Cash | -71.80M |
| Net Cash Per Share | -$0.71 |
| Equity (Book Value) | 3.69B |
| Book Value Per Share | 36.35 |
| Working Capital | 763.00M |
Cash Flow
In the last 12 months, operating cash flow was $898.10 million and capital expenditures -$27.70 million, giving a free cash flow of $870.40 million.
| Operating Cash Flow | 898.10M |
| Capital Expenditures | -27.70M |
| Depreciation & Amortization | 47.30M |
| Net Borrowing | n/a |
| Free Cash Flow | 870.40M |
| FCF Per Share | $8.56 |
Margins
Gross margin is 64.48%, with operating and profit margins of 25.67% and 20.91%.
| Gross Margin | 64.48% |
| Operating Margin | 25.67% |
| Pretax Margin | 27.87% |
| Profit Margin | 20.91% |
| EBITDA Margin | 27.07% |
| EBIT Margin | 25.67% |
| FCF Margin | 25.80% |
Dividends & Yields
NBIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.78% |
| Shareholder Yield | -0.78% |
| Earnings Yield | 4.75% |
| FCF Yield | 5.86% |
Analyst Forecast
The average price target for NBIX is $209.52, which is 43.28% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $209.52 |
| Price Target Difference | 43.28% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (3Y) | 21.40% |
| EPS Growth Forecast (3Y) | 34.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NBIX has an Altman Z-Score of 6.57 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.57 |
| Piotroski F-Score | 6 |